AIM: To examine the clinicopathological features of ovarian seromucinous borderline tumors (SMBTs) and compare them with those of mucinous borderline/atypical proliferative mucinous tumors (MB/APMTs). PATIENTS AND METHODS: Patients with SMBT between 2014 and 2018 and those with MB/APMT between 1988 and 2018 who underwent surgery at our Institution were identified. Pathological review was conducted using the 2014 World Health Organization criteria. Clinical features were compared retrospectively between SMBT and MB/APMT. RESULTS: In total, 11 (12.9%) patients with SMBT and 74 (87.1%) patients with MB/APMT were included in our study. The diagnosis of six patients with SMBT and 73 patients with MB/APMT was not revised on review. SMBT was diagnosed at a younger age (p=0.04), was of smaller size (p<0.01) and bilateral (p=0.03), coexisted with endometriosis (p<0.01), and more frequently recurred than MB/APMT (p=0.04). CONCLUSION: SMBT might be more aggressive than MB/APMT. Copyright
AIM: To examine the clinicopathological features of ovarian seromucinous borderline tumors (SMBTs) and compare them with those of mucinous borderline/atypical proliferative mucinous tumors (MB/APMTs). PATIENTS AND METHODS: Patients with SMBT between 2014 and 2018 and those with MB/APMT between 1988 and 2018 who underwent surgery at our Institution were identified. Pathological review was conducted using the 2014 World Health Organization criteria. Clinical features were compared retrospectively between SMBT and MB/APMT. RESULTS: In total, 11 (12.9%) patients with SMBT and 74 (87.1%) patients with MB/APMT were included in our study. The diagnosis of six patients with SMBT and 73 patients with MB/APMT was not revised on review. SMBT was diagnosed at a younger age (p=0.04), was of smaller size (p<0.01) and bilateral (p=0.03), coexisted with endometriosis (p<0.01), and more frequently recurred than MB/APMT (p=0.04). CONCLUSION:SMBT might be more aggressive than MB/APMT. Copyright
Authors: Russell Vang; Allen M Gown; Todd S Barry; Darren T Wheeler; Brigitte M Ronnett Journal: Int J Gynecol Pathol Date: 2006-01 Impact factor: 2.762
Authors: Augusto Pereira; Tirso Pérez-Medina; Javier F Magrina; Paul M Magtibay; Ana Rodríguez-Tapia; Irene Peregrin; Elsa Mendizabal; Luís Ortiz-Quintana Journal: Int J Gynecol Cancer Date: 2015-01 Impact factor: 3.437
Authors: Raffaele Tinelli; Andrea Tinelli; Francesco G Tinelli; Ettore Cicinelli; Antonio Malvasi Journal: Gynecol Oncol Date: 2005-10-10 Impact factor: 5.482
Authors: Heidi W Shappell; Maureen A Riopel; Ann E Smith Sehdev; Brigitte M Ronnett; Robert J Kurman Journal: Am J Surg Pathol Date: 2002-12 Impact factor: 6.394